Johnathan C. Maher
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
-
- Metabolism, Diabetes, and Cancer
- Mitochondrial Function and Pathology
- ATP Synthase and ATPases Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 10
-
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Théodore J. Lampidis (9 shared papers)Metin Kurtoğlu (7 shared papers)Awtar Krishan (3 shared papers)Niramol Savaraj (6 shared papers)Medhi Wangpaichitr (5 shared papers)Andrew N. Lane (1 shared paper)Mark A. Lehrman (1 shared paper)Jie Shang (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Johnathan C. Maher
18 papers receiving 906 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 410
- Molecular Biology 504
- Oncology 154
- Immunology 111
- Cell Biology 86
Countries citing papers authored by Johnathan C. Maher
This map shows the geographic impact of Johnathan C. Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnathan C. Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnathan C. Maher more than expected).
Fields of papers citing papers by Johnathan C. Maher
This network shows the impact of papers produced by Johnathan C. Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnathan C. Maher. The network helps show where Johnathan C. Maher may publish in the future.
Co-authors
The 25 scholars most cited alongside Johnathan C. Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 203 | |
| 2 | 2004 | 180 | |
| 3 | 2007 | 133 | |
| 4 | 2007 | 98 | |
| 5 | 2006 | 69 | |
| 6 | 2016 | 63 | |
| 7 | 2009 | 62 | |
| 8 | 2005 | 41 | |
| 9 | 2008 | 32 | |
| 10 | 2012 | 15 | |
| 11 | 2018 | 5 | |
| 12 | 2014 | 5 | |
| 13 | 2015 | 5 | |
| 14 | 2017 | 2 | |
| 15 | 2016 | 1 | |
| 16 | Inhibition of mTOR activity potentiates 2-DG-induced cell death in hypoxic cells via down-regulation of HIF-1α | 2007 | 1 |
| 17 | 2-Deoxy-D-glucose kills select tumor cell types under normoxia: reversal by mannose indicates interference with glycosylation | 2005 | 1 |
| 18 | Treatment of tumor cells with the glycolytic inhibitor, 2-deoxy-D-glucose: Effects and mechanisms of resistance | 2006 | 1 |
About Johnathan C. Maher
Johnathan C. Maher is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 18 papers that have together received 917 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (10 papers), Prostate Cancer Treatment and Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Research and Treatments (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (410 citations), Molecular Biology (504 citations), Oncology (154 citations), Immunology (111 citations) and Cell Biology (86 citations). Johnathan C. Maher has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Théodore J. Lampidis, Metin Kurtoğlu, Awtar Krishan, Niramol Savaraj, Medhi Wangpaichitr, Andrew N. Lane, Mark A. Lehrman, Jie Shang, Ningguo Gao and Waldemar Priebe. Their work appears in journals such as Molecular Cancer Therapeutics, Blood, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.